Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Just curious why nobody thought the following was worth discussing

Sure, let's discuss it.

That works out to a shareholder (ALL shareholders) value of .0175 per share.

Is that worthy of discussion? For me anyway that is worth a weekend away. Hardly worth a good palava of course in this shareholders opinion.

Good Luck,

(I) C. W.

Share
New Message
Please login to post a reply